Innoviva (INVA) Amortizatization of Intangibles (2013 - 2016)
Innoviva (INVA) posted Amortizatization of Intangibles of -$3000.0 for Q1 2016, down 105.26% on a QoQ basis from $57000.0 in Q4 2015, and down 101.29% year-over-year from $233000.0 in Q2 2015.
Innoviva (INVA) Amortizatization of Intangibles (2013 - 2016) Analysis & Trends
Innoviva's Amortizatization of Intangibles history runs 4 years deep, the most recent figure standing at -$3000.0 for Q1 2016.
- Quarterly Amortizatization of Intangibles fell 101.29% year-over-year to -$3000.0 in Q1 2016, while the trailing twelve-month figure through Mar 2016 was $347000.0 (down 71.39% YoY) and the FY2015 annual result came in at $583000.0, down 66.53% from the prior year.
- Amortizatization of Intangibles was -$3000.0 for Q1 2016 at Innoviva, down from $57000.0 in the prior quarter.
- Across five years, Amortizatization of Intangibles topped out at $1.1 million in Q3 2013 and bottomed at -$3000.0 in Q1 2016.
- A 4-year average of $387454.5 and a median of $203000.0 in 2014 frame the typical range for Amortizatization of Intangibles.
- Annual changes were most pronounced in 2015 — Amortizatization of Intangibles climbed 5.51% — and 2016, when it plunged 101.29%.
- Innoviva's Amortizatization of Intangibles stood at $861000.0 in 2013, then sank by 76.42% to $203000.0 in 2014, then plunged by 71.92% to $57000.0 in 2015, then slumped by 105.26% to -$3000.0 in 2016.
- Business Quant data shows INVA's Amortizatization of Intangibles at -$3000.0 in Q1 2016, $57000.0 in Q4 2015, and $134000.0 in Q3 2015.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | - |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 3.22 Mn |
| 10 | Innoviva | 1.58 Bn | 979.49 Mn | 75.83 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2016 | -3,000.00 |
| Mar 31, 2016 | -3,000.00 |
| Dec 31, 2015 | 57,000.00 |
| Dec 31, 2015 | 57,000.00 |
| Sep 30, 2015 | 134,000.00 |
| Sep 30, 2015 | 134,000.00 |
| Jun 30, 2015 | 159,000.00 |
| Jun 30, 2015 | 159,000.00 |
| Mar 31, 2015 | 233,000.00 |
| Mar 31, 2015 | 233,000.00 |
| Dec 31, 2014 | 203,000.00 |
| Dec 31, 2014 | 203,000.00 |
| Sep 30, 2014 | 127,000.00 |
| Sep 30, 2014 | 127,000.00 |
| Jun 30, 2014 | 650,000.00 |
| Jun 30, 2014 | 650,000.00 |
| Mar 31, 2014 | 762,000.00 |
| Mar 31, 2014 | 762,000.00 |
| Dec 31, 2013 | 861,000.00 |
| Dec 31, 2013 | 861,000.00 |